<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">30126841</PMID><DateCompleted><Year>2019</Year><Month>03</Month><Day>04</Day></DateCompleted><DateRevised><Year>2021</Year><Month>02</Month><Day>05</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1083-351X</ISSN><JournalIssue CitedMedium="Internet"><Volume>293</Volume><Issue>40</Issue><PubDate><Year>2018</Year><Month>Oct</Month><Day>05</Day></PubDate></JournalIssue><Title>The Journal of biological chemistry</Title><ISOAbbreviation>J Biol Chem</ISOAbbreviation></Journal><ArticleTitle>Molecular mechanism of poliovirus Sabin vaccine strain attenuation.</ArticleTitle><Pagination><StartPage>15471</StartPage><EndPage>15482</EndPage><MedlinePgn>15471-15482</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1074/jbc.RA118.004913</ELocationID><Abstract><AbstractText>Recruitment of poliovirus (PV) RNA to the human ribosome requires the coordinated interaction of the viral internal ribosome entry site (IRES) and several host cellular initiation factors and IRES <i>trans</i>-acting factors (ITAFs). Attenuated PV Sabin strains contain point mutations in the PV IRES domain V (dV) that inhibit viral translation. Remarkably, attenuation is most apparent in cells of the central nervous system, but the molecular basis to explain this is poorly understood. The dV contains binding sites for eukaryotic initiation factor 4G (eIF4G) and polypyrimidine tract-binding protein (PTB). Impaired binding of these proteins to the mutant IRESs has been observed, but these effects have not been quantitated. We used a fluorescence anisotropy assay to reveal that the Sabin mutants reduce the equilibrium dissociation constants of eIF4G and PTB to the PV IRES by up to 6-fold. Using the most inhibitory Sabin 3 mutant, we used a real-time fluorescence helicase assay to show that the apparent affinity of an active eIF4G/4A/4B helicase complex for the IRES is reduced by 2.5-fold. The Sabin 3 mutant did not alter the maximum rate of eIF4A-dependent helicase activity, suggesting that this mutant primarily reduces the affinity, rather than activity, of the unwinding complex. To confirm this affinity model of attenuation, we show that eIF4G overexpression in HeLa cells overcomes the attenuation of a Sabin 3 mutant PV-luciferase replicon. Our study provides a quantitative framework for understanding the mechanism of PV Sabin attenuation and provides an explanation for the previously observed cell type-specific translational attenuation.</AbstractText><CopyrightInformation>&#xa9; 2018 Avanzino et al.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Avanzino</LastName><ForeName>Brian C</ForeName><Initials>BC</Initials><AffiliationInfo><Affiliation>From the Department of Molecular and Cellular Biology, College of Biological Sciences, University of California, Davis, California 95616 and.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jue</LastName><ForeName>Helen</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>From the Department of Molecular and Cellular Biology, College of Biological Sciences, University of California, Davis, California 95616 and.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Miller</LastName><ForeName>Clare M</ForeName><Initials>CM</Initials><AffiliationInfo><Affiliation>the Department of Biological Sciences, The RNA Institute, University at Albany, State University of New York, Albany, New York 12222.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cheung</LastName><ForeName>Emily</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>the Department of Biological Sciences, The RNA Institute, University at Albany, State University of New York, Albany, New York 12222.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fuchs</LastName><ForeName>Gabriele</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>the Department of Biological Sciences, The RNA Institute, University at Albany, State University of New York, Albany, New York 12222 gfuchs@albany.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fraser</LastName><ForeName>Christopher S</ForeName><Initials>CS</Initials><AffiliationInfo><Affiliation>From the Department of Molecular and Cellular Biology, College of Biological Sciences, University of California, Davis, California 95616 and csfraser@ucdavis.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 GM092927</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>08</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Biol Chem</MedlineTA><NlmUniqueID>2985121R</NlmUniqueID><ISSNLinking>0021-9258</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D039603">Eukaryotic Initiation Factor-4G</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000067556">Internal Ribosome Entry Sites</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011055">Poliovirus Vaccine, Oral</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011994">Recombinant Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014613">Vaccines, Attenuated</NameOfSubstance></Chemical><Chemical><RegistryNumber>139076-35-0</RegistryNumber><NameOfSubstance UI="D038941">Polypyrimidine Tract-Binding Protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.13.12.-</RegistryNumber><NameOfSubstance UI="D008156">Luciferases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.7.-</RegistryNumber><NameOfSubstance UI="D039601">Eukaryotic Initiation Factor-4A</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016367" MajorTopicYN="N">Baculoviridae</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001483" MajorTopicYN="N">Base Sequence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003001" MajorTopicYN="N">Cloning, Molecular</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004926" MajorTopicYN="N">Escherichia coli</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D039601" MajorTopicYN="N">Eukaryotic Initiation Factor-4A</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D039603" MajorTopicYN="N">Eukaryotic Initiation Factor-4G</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015870" MajorTopicYN="N">Gene Expression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017930" MajorTopicYN="N">Genes, Reporter</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005822" MajorTopicYN="N">Genetic Vectors</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006367" MajorTopicYN="N">HeLa Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000067556" MajorTopicYN="N">Internal Ribosome Entry Sites</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008156" MajorTopicYN="N">Luciferases</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="Y">Mutation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009690" MajorTopicYN="N">Nucleic Acid Conformation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017955" MajorTopicYN="N">Poliovirus</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011055" MajorTopicYN="N">Poliovirus Vaccine, Oral</DescriptorName><QualifierName UI="Q000096" MajorTopicYN="N">biosynthesis</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D038941" MajorTopicYN="N">Polypyrimidine Tract-Binding Protein</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014176" MajorTopicYN="Y">Protein Biosynthesis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011994" MajorTopicYN="N">Recombinant Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016415" MajorTopicYN="N">Sequence Alignment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D061987" MajorTopicYN="N">Sf9 Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018411" MajorTopicYN="N">Spodoptera</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014613" MajorTopicYN="N">Vaccines, Attenuated</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">RNA-binding protein</Keyword><Keyword MajorTopicYN="N">eukaryotic initiation factor 4A (eIF4A)</Keyword><Keyword MajorTopicYN="N">eukaryotic translation initiation</Keyword><Keyword MajorTopicYN="N">eukaryotic translation initiation factor 4G (eIF4G)</Keyword><Keyword MajorTopicYN="N">internal ribosome entry site (IRES)</Keyword><Keyword MajorTopicYN="N">plus-stranded RNA virus</Keyword><Keyword MajorTopicYN="N">poliovirus</Keyword><Keyword MajorTopicYN="N">vaccine</Keyword><Keyword MajorTopicYN="N">virulence</Keyword></KeywordList><CoiStatement>The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>7</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2018</Year><Month>8</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>8</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>3</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>8</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2019</Year><Month>10</Month><Day>5</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30126841</ArticleId><ArticleId IdType="pmc">PMC6177584</ArticleId><ArticleId IdType="doi">10.1074/jbc.RA118.004913</ArticleId><ArticleId IdType="pii">S0021-9258(20)35252-2</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Sabin A. B. (1985) Oral poliovirus vaccine: history of its development and use and current challenge to eliminate poliomyelitis from the world. J. Infect. Dis. 151, 420&#x2013;436 10.1093/infdis/151.3.420</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/151.3.420</ArticleId><ArticleId IdType="pubmed">2982959</ArticleId></ArticleIdList></Reference><Reference><Citation>Almond J. W. (1987) The attenuation of poliovirus neurovirulence. Annu. Rev. Microbiol. 41, 153&#x2013;180 10.1146/annurev.mi.41.100187.001101</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.mi.41.100187.001101</ArticleId><ArticleId IdType="pubmed">2825586</ArticleId></ArticleIdList></Reference><Reference><Citation>Racaniello V. R. (1988) Poliovirus neurovirulence. Adv. Virus Res. 34, 217&#x2013;246 10.1016/S0065-3527(08)60519-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0065-3527(08)60519-9</ArticleId><ArticleId IdType="pubmed">2843017</ArticleId></ArticleIdList></Reference><Reference><Citation>La Monica N., and Racaniello V. R. (1989) Differences in replication of attenuated and neurovirulent polioviruses in human neuroblastoma cell line SH-SY5Y. J. Virol. 63, 2357&#x2013;2360</Citation><ArticleIdList><ArticleId IdType="pmc">PMC250657</ArticleId><ArticleId IdType="pubmed">2539524</ArticleId></ArticleIdList></Reference><Reference><Citation>Malnou C. E., Werner A., Borman A. M., Westhof E., and Kean K. M. (2004) Effects of vaccine strain mutations in domain V of the internal ribosome entry segment compared in the wild-type poliovirus type 1 context. J. Biol. Chem. 279, 10261&#x2013;10269 10.1074/jbc.M307806200</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M307806200</ArticleId><ArticleId IdType="pubmed">14672927</ArticleId></ArticleIdList></Reference><Reference><Citation>Ochs K., Zeller A., Saleh L., Bassili G., Song Y., Sonntag A., and Niepmann M. (2003) Impaired binding of standard initiation factors mediates poliovirus translation attenuation. J. Virol. 77, 115&#x2013;122 10.1128/JVI.77.1.115-122.2003</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.77.1.115-122.2003</ArticleId><ArticleId IdType="pmc">PMC140626</ArticleId><ArticleId IdType="pubmed">12477816</ArticleId></ArticleIdList></Reference><Reference><Citation>Svitkin Y. V., Cammack N., Minor P. D., and Almond J. W. (1990) Translation deficiency of the Sabin type 3 poliovirus genome: association with an attenuating mutation C472&#x2014;U. Virology 175, 103&#x2013;109 10.1016/0042-6822(90)90190-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0042-6822(90)90190-3</ArticleId><ArticleId IdType="pubmed">2155504</ArticleId></ArticleIdList></Reference><Reference><Citation>Svitkin Y. V., Maslova S. V., and Agol V. I. (1985) The genomes of attenuated and virulent poliovirus strains differ in their in vitro translation efficiencies. Virology 147, 243&#x2013;252 10.1016/0042-6822(85)90127-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0042-6822(85)90127-8</ArticleId><ArticleId IdType="pubmed">3000069</ArticleId></ArticleIdList></Reference><Reference><Citation>de Breyne S., Yu Y., Unbehaun A., Pestova T. V., and Hellen C. U. (2009) Direct functional interaction of initiation factor eIF4G with type 1 internal ribosomal entry sites. Proc. Natl. Acad. Sci. U.S.A. 106, 9197&#x2013;9202 10.1073/pnas.0900153106</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0900153106</ArticleId><ArticleId IdType="pmc">PMC2695064</ArticleId><ArticleId IdType="pubmed">19470487</ArticleId></ArticleIdList></Reference><Reference><Citation>Ochs K., Saleh L., Bassili G., Sonntag V. H., Zeller A., and Niepmann M. (2002) Interaction of translation initiation factor eIF4B with the poliovirus internal ribosome entry site. J. Virol. 76, 2113&#x2013;2122 10.1128/jvi.76.5.2113-2122.2002</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.76.5.2113-2122.2002</ArticleId><ArticleId IdType="pmc">PMC135939</ArticleId><ArticleId IdType="pubmed">11836388</ArticleId></ArticleIdList></Reference><Reference><Citation>Hellen C. U., Witherell G. W., Schmid M., Shin S. H., Pestova T. V., Gil A., and Wimmer E. (1993) A cytoplasmic 57-kDa protein that is required for translation of picornavirus RNA by internal ribosomal entry is identical to the nuclear pyrimidine tract-binding protein. Proc. Natl. Acad. Sci. U.S.A. 90, 7642&#x2013;7646 10.1073/pnas.90.16.7642</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.90.16.7642</ArticleId><ArticleId IdType="pmc">PMC47198</ArticleId><ArticleId IdType="pubmed">8395052</ArticleId></ArticleIdList></Reference><Reference><Citation>Hunt S. L., and Jackson R. J. (1999) Polypyrimidine-tract binding protein (PTB) is necessary, but not sufficient, for efficient internal initiation of translation of human rhinovirus-2 RNA. RNA 5, 344&#x2013;359 10.1017/S1355838299981414</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S1355838299981414</ArticleId><ArticleId IdType="pmc">PMC1369764</ArticleId><ArticleId IdType="pubmed">10094304</ArticleId></ArticleIdList></Reference><Reference><Citation>Meerovitch K., Svitkin Y. V., Lee H. S., Lejbkowicz F., Kenan D. J., Chan E. K., Agol V. I., Keene J. D., and Sonenberg N. (1993) La autoantigen enhances and corrects aberrant translation of poliovirus RNA in reticulocyte lysate. J. Virol. 67, 3798&#x2013;3807</Citation><ArticleIdList><ArticleId IdType="pmc">PMC237744</ArticleId><ArticleId IdType="pubmed">8389906</ArticleId></ArticleIdList></Reference><Reference><Citation>Blyn L. B., Towner J. S., Semler B. L., and Ehrenfeld E. (1997) Requirement of poly(rC) binding protein 2 for translation of poliovirus RNA. J. Virol. 71, 6243&#x2013;6246</Citation><ArticleIdList><ArticleId IdType="pmc">PMC191892</ArticleId><ArticleId IdType="pubmed">9223526</ArticleId></ArticleIdList></Reference><Reference><Citation>Hellen C. U., Pestova T. V., Litterst M., and Wimmer E. (1994) The cellular polypeptide p57 (pyrimidine tract-binding protein) binds to multiple sites in the poliovirus 5&#x2032; nontranslated region. J. Virol. 68, 941&#x2013;950</Citation><ArticleIdList><ArticleId IdType="pmc">PMC236532</ArticleId><ArticleId IdType="pubmed">8289396</ArticleId></ArticleIdList></Reference><Reference><Citation>Kafasla P., Morgner N., Robinson C. V., and Jackson R. J. (2010) Polypyrimidine tract-binding protein stimulates the poliovirus IRES by modulating eIF4G binding. EMBO J. 29, 3710&#x2013;3722 10.1038/emboj.2010.231</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/emboj.2010.231</ArticleId><ArticleId IdType="pmc">PMC2982756</ArticleId><ArticleId IdType="pubmed">20859255</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawamura N., Kohara M., Abe S., Komatsu T., Tago K., Arita M., and Nomoto A. (1989) Determinants in the 5&#x2032; noncoding region of poliovirus Sabin 1 RNA that influence the attenuation phenotype. J. Virol. 63, 1302&#x2013;1309</Citation><ArticleIdList><ArticleId IdType="pmc">PMC247827</ArticleId><ArticleId IdType="pubmed">2536835</ArticleId></ArticleIdList></Reference><Reference><Citation>Moss E. G., O'Neill R. E., and Racaniello V. R. (1989) Mapping of attenuating sequences of an avirulent poliovirus type 2 strain. J. Virol. 63, 1884&#x2013;1890</Citation><ArticleIdList><ArticleId IdType="pmc">PMC250599</ArticleId><ArticleId IdType="pubmed">2539491</ArticleId></ArticleIdList></Reference><Reference><Citation>Westrop G. D., Wareham K. A., Evans D. M., Dunn G., Minor P. D., Magrath D. I., Taffs F., Marsden S., Skinner M. A., and Schild G. C. (1989) Genetic basis of attenuation of the Sabin type 3 oral poliovirus vaccine. J. Virol. 63, 1338&#x2013;1344</Citation><ArticleIdList><ArticleId IdType="pmc">PMC247831</ArticleId><ArticleId IdType="pubmed">2536836</ArticleId></ArticleIdList></Reference><Reference><Citation>Guest S., Pilipenko E., Sharma K., Chumakov K., and Roos R. P. (2004) Molecular mechanisms of attenuation of the Sabin strain of poliovirus type 3. J. Virol. 78, 11097&#x2013;11107 10.1128/JVI.78.20.11097-11107.2004</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.78.20.11097-11107.2004</ArticleId><ArticleId IdType="pmc">PMC521805</ArticleId><ArticleId IdType="pubmed">15452230</ArticleId></ArticleIdList></Reference><Reference><Citation>Guti&#xe9;rrez A. L., Denova-Ocampo M., Racaniello V. R., and del Angel R. M. (1997) Attenuating mutations in the poliovirus 5&#x2032; untranslated region alter its interaction with polypyrimidine tract-binding protein. J. Virol. 71, 3826&#x2013;3833</Citation><ArticleIdList><ArticleId IdType="pmc">PMC191533</ArticleId><ArticleId IdType="pubmed">9094658</ArticleId></ArticleIdList></Reference><Reference><Citation>Ohka S., and Nomoto A. (2001) The molecular basis of poliovirus neurovirulence. Dev. Biol. (Basel) 105, 51&#x2013;58</Citation><ArticleIdList><ArticleId IdType="pubmed">11763337</ArticleId></ArticleIdList></Reference><Reference><Citation>Kauder S. E., and Racaniello V. R. (2004) Poliovirus tropism and attenuation are determined after internal ribosome entry. J. Clin. Invest. 113, 1743&#x2013;1753 10.1172/JCI200421323</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI200421323</ArticleId><ArticleId IdType="pmc">PMC420511</ArticleId><ArticleId IdType="pubmed">15199409</ArticleId></ArticleIdList></Reference><Reference><Citation>Avanzino B. C., Fuchs G., and Fraser C. S. (2017) Cellular cap-binding protein, eIF4E, promotes picornavirus genome restructuring and translation. Proc. Natl. Acad. Sci. U.S.A. 114, 9611&#x2013;9616 10.1073/pnas.1704390114</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1704390114</ArticleId><ArticleId IdType="pmc">PMC5594656</ArticleId><ArticleId IdType="pubmed">28827335</ArticleId></ArticleIdList></Reference><Reference><Citation>Sokabe M., and Fraser C. S. (2017) A helicase-independent activity of eIF4A in promoting mRNA recruitment to the human ribosome. Proc. Natl. Acad. Sci. U.S.A. 114, 6304&#x2013;6309 10.1073/pnas.1620426114</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1620426114</ArticleId><ArticleId IdType="pmc">PMC5474785</ArticleId><ArticleId IdType="pubmed">28559306</ArticleId></ArticleIdList></Reference><Reference><Citation>Bordeleau M. E., Mori A., Oberer M., Lindqvist L., Chard L. S., Higa T., Belsham G. J., Wagner G., Tanaka J., and Pelletier J. (2006) Functional characterization of IRESes by an inhibitor of the RNA helicase eIF4A. Nat. Chem. Biol. 2, 213&#x2013;220 10.1038/nchembio776</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nchembio776</ArticleId><ArticleId IdType="pubmed">16532013</ArticleId></ArticleIdList></Reference><Reference><Citation>Pause A., M&#xe9;thot N., Svitkin Y., Merrick W. C., and Sonenberg N. (1994) Dominant negative mutants of mammalian translation initiation factor eIF-4A define a critical role for eIF-4F in cap-dependent and cap-independent initiation of translation. EMBO J. 13, 1205&#x2013;1215</Citation><ArticleIdList><ArticleId IdType="pmc">PMC394930</ArticleId><ArticleId IdType="pubmed">8131750</ArticleId></ArticleIdList></Reference><Reference><Citation>&#xd6;zes A. R., Feoktistova K., Avanzino B. C., Baldwin E. P., and Fraser C. S. (2014) Real-time fluorescence assays to monitor duplex unwinding and ATPase activities of helicases. Nat. Protoc. 9, 1645&#x2013;1661 10.1038/nprot.2014.112</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nprot.2014.112</ArticleId><ArticleId IdType="pmc">PMC5524973</ArticleId><ArticleId IdType="pubmed">24945382</ArticleId></ArticleIdList></Reference><Reference><Citation>&#xd6;zes A. R., Feoktistova K., Avanzino B. C., and Fraser C. S. (2011) Duplex unwinding and ATPase activities of the DEAD-box helicase eIF4A are coupled by eIF4G and eIF4B. J. Mol. Biol. 412, 674&#x2013;687 10.1016/j.jmb.2011.08.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmb.2011.08.004</ArticleId><ArticleId IdType="pmc">PMC3175293</ArticleId><ArticleId IdType="pubmed">21840318</ArticleId></ArticleIdList></Reference><Reference><Citation>Haller A. A., Stewart S. R., and Semler B. L. (1996) Attenuation stem-loop lesions in the 5&#x2032; noncoding region of poliovirus RNA: neuronal cell-specific translation defects. J. Virol. 70, 1467&#x2013;1474</Citation><ArticleIdList><ArticleId IdType="pmc">PMC189967</ArticleId><ArticleId IdType="pubmed">8627664</ArticleId></ArticleIdList></Reference><Reference><Citation>Vogt D. A., and Andino R. (2010) An RNA element at the 5&#x2032;-end of the poliovirus genome functions as a general promoter for RNA synthesis. PLoS Pathog. 6, e1000936 10.1371/journal.ppat.1000936</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1000936</ArticleId><ArticleId IdType="pmc">PMC2880563</ArticleId><ArticleId IdType="pubmed">20532207</ArticleId></ArticleIdList></Reference><Reference><Citation>Moerke N. J., Aktas H., Chen H., Cantel S., Reibarkh M. Y., Fahmy A., Gross J. D., Degterev A., Yuan J., Chorev M., Halperin J. A., and Wagner G. (2007) Small-molecule inhibition of the interaction between the translation initiation factors eIF4E and eIF4G. Cell 128, 257&#x2013;267 10.1016/j.cell.2006.11.046</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2006.11.046</ArticleId><ArticleId IdType="pubmed">17254965</ArticleId></ArticleIdList></Reference><Reference><Citation>Agol V. I., Drozdov S. G., Ivannikova T. A., Kolesnikova M. S., Korolev M. B., and Tolskaya E. A. (1989) Restricted growth of attenuated poliovirus strains in cultured cells of a human neuroblastoma. J. Virol. 63, 4034&#x2013;4038</Citation><ArticleIdList><ArticleId IdType="pmc">PMC251001</ArticleId><ArticleId IdType="pubmed">2548013</ArticleId></ArticleIdList></Reference><Reference><Citation>Lillev&#xe4;li K., Kulla A., and Ord T. (2001) Comparative expression analysis of the genes encoding polypyrimidine tract binding protein (PTB) and its neural homologue (brPTB) in prenatal and postnatal mouse brain. Mech. Dev. 101, 217&#x2013;220 10.1016/S0925-4773(00)00566-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0925-4773(00)00566-9</ArticleId><ArticleId IdType="pubmed">11231079</ArticleId></ArticleIdList></Reference><Reference><Citation>Markovtsov V., Nikolic J. M., Goldman J. A., Turck C. W., Chou M. Y., and Black D. L. (2000) Cooperative assembly of an hnRNP complex induced by a tissue-specific homolog of polypyrimidine tract binding protein. Mol. Cell. Biol. 20, 7463&#x2013;7479 10.1128/MCB.20.20.7463-7479.2000</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MCB.20.20.7463-7479.2000</ArticleId><ArticleId IdType="pmc">PMC86300</ArticleId><ArticleId IdType="pubmed">11003644</ArticleId></ArticleIdList></Reference><Reference><Citation>Goetz C., Dobrikova E., Shveygert M., Dobrikov M., and Gromeier M. (2011) Oncolytic poliovirus against malignant glioma. Future Virol. 6, 1045&#x2013;1058 10.2217/fvl.11.76</Citation><ArticleIdList><ArticleId IdType="doi">10.2217/fvl.11.76</ArticleId><ArticleId IdType="pmc">PMC3187927</ArticleId><ArticleId IdType="pubmed">21984883</ArticleId></ArticleIdList></Reference><Reference><Citation>Feoktistova K., Tuvshintogs E., Do A., and Fraser C. S. (2013) Human eIF4E promotes mRNA restructuring by stimulating eIF4A helicase activity. Proc. Natl. Acad. Sci. U.S.A. 110, 13339&#x2013;13344 10.1073/pnas.1303781110</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1303781110</ArticleId><ArticleId IdType="pmc">PMC3746923</ArticleId><ArticleId IdType="pubmed">23901100</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaiser C., Dobrikova E. Y., Bradrick S. S., Shveygert M., Herbert J. T., and Gromeier M. (2008) Activation of cap-independent translation by variant eukaryotic initiation factor 4G in vivo. RNA 14, 2170&#x2013;2182 10.1261/rna.1171808</Citation><ArticleIdList><ArticleId IdType="doi">10.1261/rna.1171808</ArticleId><ArticleId IdType="pmc">PMC2553731</ArticleId><ArticleId IdType="pubmed">18755839</ArticleId></ArticleIdList></Reference><Reference><Citation>Sokabe M., and Fraser C. S. (2014) Human eukaryotic initiation factor 2 (eIF2)-GTP-Met-tRNAi ternary complex and eIF3 stabilize the 43 S preinitiation complex. J. Biol. Chem. 289, 31827&#x2013;31836 10.1074/jbc.M114.602870</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M114.602870</ArticleId><ArticleId IdType="pmc">PMC4231660</ArticleId><ArticleId IdType="pubmed">25246524</ArticleId></ArticleIdList></Reference><Reference><Citation>Villa N., Do A., Hershey J. W., and Fraser C. S. (2013) Human eukaryotic initiation factor 4G (eIF4G) protein binds to eIF3c, -d, and -e to promote mRNA recruitment to the ribosome. J. Biol. Chem. 288, 32932&#x2013;32940 10.1074/jbc.M113.517011</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M113.517011</ArticleId><ArticleId IdType="pmc">PMC3829144</ArticleId><ArticleId IdType="pubmed">24092755</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>